Family Med Journals

Family Med

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Winzenberg T et al. - Gout afflicts about 2% of men over age 30 and women over age 50 and its prevalence appears to be increasing. Options for treating acute gout include nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, and intra-articular and systemic corticosteroids. Choosing among them can be challenging, however, because the evidence that one or another of these options yields real benefit is of varying strength. Using NSAIDs can be problematic with increasing age, as comorbidities like gastrointestinal (GI) bleeding, renal failure, heart failure, and cardiovascular risk increase and anticoagulant therapy is more likely to be in use. That’s where the kind of systematic reviews Cochrane Musculoskeletal Group (CMSG) performs can be of real help.

 

Related Articles

Outcome Domains for Studies of Acute and Chronic Gout
Journal of Rheumatology, 10/20/09    Relevance Score: 69%

Progress in Measurement Instruments for Acute and Chronic Gout Studies
Journal of Rheumatology, 10/23/09    Relevance Score: 68%

The modern management of gout
Rheumatology, 10/08/09    Relevance Score: 66%

Acute chylous ascites mimicking acute appendicitis in a patient with pancreatitis
World Journal of Gastroenterology, 10/20/09    Relevance Score: 47%

Acute silent cerebral infarction in children with sickle cell anemia
Pediatric Blood & Cancer, 10/09/09    Relevance Score: 46%

Today in Clinical Pharmacology...keeping you current

Concomitant or adjuvant temozolomide with whole-brain irradiation for brain metastases: a meta-analysis
Anti-Cancer Drugs, 12/09/09

Developments in factor Xa inhibitors for the treatment of thromboembolic disorders
Medicinal Research Reviews, 12/09/09

Cyclooxygenase inhibitors: Scope of their use and development in cancer chemotherapy
Medicinal Research Reviews, 12/09/09